Why Remdesivir is no ‘Ram-Ban’ to cure COVID-19

India

oi-Vicky Nanjappa

|

New Delhi, Apr 22: Through a graded, pre-emptive and pro-active approach, Government of India is taking several steps along with the States/UTs under a ‘whole of government’ approach for prevention, containment and management of the recent surge in COVID-19 cases. These are also being regularly reviewed and monitored at the highest level.

The DPIIT, in consultation with all stakeholders has issued a supply mapping plan for 12 high burden states till 30th April. The Home Ministry’s advisory on unhindered movement of oxygen across states, the installation of 162 PSA Oxygen plants (154.19 MT capacity) in 32 States/UTs from PM-CARES fund, Operationalization of the IT application, ‘Medsupply’ which tracks site readiness, plant delivery, installation & commissioning, augmentation of Remdesivir production to around 74.10 lakh vials/month (May)from 27-29 lakh vials/month (Jan-Feb),…

Exit mobile version